Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Clinical trial NCT07454837 · RECRUITING
Trial details
- NCT number
- NCT07454837
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-26
- Primary completion
- 2027-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.